Developing Targeted Oncolytic Viral Immunotherapy for the Treatment of Cancer

 

Cynvec is an immuno-oncology company developing innovative oncolytic viral immunotherapies that harness the patient’s own immune system to fight cancer.

 

 

SaveSave